{content:title}

Citations Database

Researchers from across the world have utilized Biointron services and products to support their studies. As a comprehensive overview, we have gathered a database of citations that showcase the widespread utilization of Biointron within the scientific community.

Get a 25% off discount when you cite Biointron in your research paper! More info here.

Product/Service
Antibody or Protein Production Catalog Products Antibody Discovery Hybridoma Sequencing
Journal
Acta Pharmaceutica Sinica B Advanced Healthcare Materials Antibodies Antibody Therapeutics Biosensors Cancer Immunology Research Cancer Letters Cancer Research Communications Cancers Carbohydrate Polymers Cell Biomaterials Cell Death and Disease Cell Research Cell Systems EMBO Molecular Medicine eBioMedicine European Journal of Immunology Food and Agricultural Immunology Frontiers in Immunology iScience Immunopharmacology and Immunotoxicology Immunotherapy JCI Insight Journal for ImmunoTherapy of Cancer Journal of Autoimmunity Journal of Bone and Mineral Research Journal of Healthcare Engineering Journal of Immunological Methods Journal of Immunotherapy Journal of Virology MAbs Molecular Cancer Therapeutics Molecular Metabolism Nature Chemical Biology Nature Communications Neurotoxicity Research npj Vaccines Oncogene Research Science Advances Science China Life Sciences Science Immunology Scientific Reports Small Viruses
Developing drug-like single-domain antibodies (VHH) from in vitro libraries

Authors: M Frank Erasmus, Andre A R Teixeira, Esteban Molina, Luis Antonio Rodriguez Carnero, Jianquan Li, David Knight, Roberto Di Niro, Camila Leal-Lopes, Adeline Fanni, Hallie Troell, Ashley DeAguero, Laura Spector, Sara D'Angelo, Fortunato Ferrara, Andrew R M Bradbury

Journal: MAbs

PubMed ID: 40562779

DOI: https://doi.org/10.1080/19420862.2025.2516676

Products & Services: Monomeric VHH and dimeric VHH-Fc (human IgG1 Fc domain, C220S mutation to eliminate unpaired cysteine) fusions were expressed by BioIntron using their high-throughput 4 ml/100 µg scale expression system.


Jun 25, 2025
Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies

Authors: Yizhou Zhang,Ruicheng Wei,Ge Song,Xinyi Yang,Mengli Zhang,Wei Liu,Aiying Xiong,Xuehan Zhang,Qianhao Li,Wan-Jen Yang,Chencheng Han,Rui Liu,Chen Hu,Qingyu Wang,Jun Zhu & Yongqiang Shan

Journal: Mabs

PubMed ID: 39497266

DOI: https://doi.org/10.1080/19420862.2024.2419838

Products & Services: B2014, B6924

Nov 04, 2024

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.